Xanthine oxidoreductase (XOR), the rate-limiting enzyme of UA production, was recently reported to be upregulated in fat, liver, kidneys, and the vasculature of patients with T2DM and other metabolic diseases [15,16]. Here, XDH is linked to Other metabolic disease.